Search Results - "Porterie, P"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Natural inhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant by Kordich, L C, Forastiero, R R, Basilotta, E, Porterie, P, Carreras, L O

    Published in Blood coagulation & fibrinolysis (01-12-1992)
    “…We studied the natural inhibitors (NI) of blood coagulation and fibrinolysis in 50 patients with lupus anticoagulant (LA), in order to identify possible…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Mini-plasminogen like molecule in septic patients by Kordich, L C, Porterie, V P, Lago, O, Bergonzelli, G E, Sassetti, B, Sanchez Avalos, J C

    Published in Thrombosis research (01-09-1987)
    “…Plasma from 7 septic patients with positive blood cultures were studied. None of them presented either clinical or laboratory evidence of Disseminated…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Plasminogen: an important hemostatic parameter in septic patients by Duboscq, C, Quintana, I, Bassilotta, E, Bergonzelli, G E, Porterie, P, Sassetti, B, Haedo, A S, Wainsztein, N, Kruithof, E K, Kordich, L

    Published in Thrombosis and haemostasis (01-06-1997)
    “…Previously we observed in some but not all septic patients a low plasma concentration of plasminogen. To investigate prospectively whether plasma levels of…”
    Get more information
    Journal Article
  6. 6

    Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency by Kordich, L, Feldman, L, Porterie, P, Lago, O

    Published in Thrombosis research (01-12-1985)
    “…We report a case of partial deficiency of alpha 2-antiplasmin. A 45 year old Spanish man had a life long severe bleeding tendency after trauma. Routine…”
    Get more information
    Journal Article
  7. 7

    Plasminogen abnormalities in patients with Argentine hemorrhagic fever by Molinas, F C, Kordich, L, Porterie, P, Lerer, G, Maiztegui, J I

    Published in Thrombosis research (15-12-1987)
    “…Plasminogen, alpha 2-antiplasmin, alpha 2-macroglobulin, alpha 1-antitrypsin and fibrinogen degradation products (FDP) were studied in 45 patients with…”
    Get more information
    Journal Article